KROS

$0.00

(

+0.00%

)
Quote details

stock

Keros Therapeutics Inc

NASDAQ | KROS

15.89

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$637.66M

Market Cap

49.06

P/E Ratio

0.32

EPS

$72.37

52 Week High

$9.11

52 Week Low

HEALTHCARE

Sector

KROS Chart

Recent Chart
Price Action

KROS Technicals

Tags:

KROS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.6M
Total Revenue $3.6M
Cost Of Revenue $1.2M
Costof Goods And Services Sold $1.2M
Operating Income -$211M
Selling General And Administrative $41M
Research And Development $174M
Operating Expenses $214M
Investment Income Net -
Net Interest Income $0
Interest Income -
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$187M
Income Tax Expense $300K
Interest And Debt Expense -
Net Income From Continuing Operations -$187M
Comprehensive Income Net Of Tax -
Ebit -$187M
Ebitda -$186M
Net Income -$187M

Revenue & Profitability

Earnings Performance

KROS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $616M
Total Current Assets $589M
Cash And Cash Equivalents At Carrying Value $560M
Cash And Short Term Investments $560M
Inventory -
Current Net Receivables $4.5M
Total Non Current Assets $27M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $25M
Other Non Current Assets -
Total Liabilities $44M
Total Current Liabilities $27M
Current Accounts Payable $4.6M
Deferred Revenue -
Current Debt -
Short Term Debt $2M
Total Non Current Liabilities $17M
Capital Lease Obligations $19M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $19M
Other Current Liabilities $21M
Other Non Current Liabilities -
Total Shareholder Equity $572M
Treasury Stock -
Retained Earnings -$569M
Common Stock $4K
Common Stock Shares Outstanding $37M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$161M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.2M
Capital Expenditures $1.9M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$1.9M
Cashflow From Financing $392M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$187M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $3.6M
Total Revenue $3.6M
Cost Of Revenue $1.2M
Costof Goods And Services Sold $1.2M
Operating Income -$211M
Selling General And Administrative $41M
Research And Development $174M
Operating Expenses $214M
Investment Income Net -
Net Interest Income $0
Interest Income -
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.2M
Income Before Tax -$187M
Income Tax Expense $300K
Interest And Debt Expense -
Net Income From Continuing Operations -$187M
Comprehensive Income Net Of Tax -
Ebit -$187M
Ebitda -$186M
Net Income -$187M

KROS News

KROS Profile

Keros Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative therapies aimed at addressing significant unmet medical needs in hematological and musculoskeletal disorders. Headquartered in Lexington, Massachusetts, the company is advancing its proprietary pipeline of drug candidates designed to improve patient outcomes in these challenging therapeutic areas. With a strong focus on scientific innovation, Keros is positioned to make a meaningful impact on the lives of patients and expand treatment options in the biopharmaceutical landscape.

VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
INTC
-3.78%
$36.36
PLUG
+13.30%
$3.87
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
VHAI
-25.00%
$0.00
YYAI
-10.47%
$0.17
STAI
+39.44%
$0.62
BURU
+7.15%
$0.50
CGBS
-39.47%
$0.03
ELBM
+325.45%
$7.02
INTC
-3.78%
$36.36
PLUG
+13.30%
$3.87
RGTI
+25.02%
$54.91
GWH
+118.14%
$9.07
NVDA
+2.81%
$188.32
BITF
+28.33%
$5.39
ASST
-30.54%
$1.08
IONZ
-32.55%
$2.29
BYND
-48.50%
$1.03
NVTS
+21.14%
$9.97
JOBY
+2.94%
$16.76
DNN
+7.11%
$3.08
EPWK
-21.60%
$0.09
GPUS
-12.48%
$0.42
QBTS
+22.83%
$40.56
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
F
+1.18%
$11.54
WULF
-0.58%
$13.51
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
PFE
-1.82%
$24.78
CRML
+55.40%
$23.28
TSLA
+5.01%
$434.23
QS
+15.57%
$16.98
SOFI
+3.62%
$27.14
ETHD
-12.95%
$3.32
RXRX
+3.94%
$5.53
NIO
+6.59%
$7.15
APLD
+0.73%
$34.24
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
DFLI
+44.03%
$1.57
AMD
+0.40%
$215.76
QUBT
-10.81%
$19.01
PWM
+12.50%
$1.17
NAK
+29.80%
$2.63
SOUN
+10.25%
$19.14
LAES
+13.30%
$6.13
ONDS
+17.24%
$10.81
DVLT
-10.52%
$1.70
CIFR
+19.77%
$20.32
USAR
+18.61%
$38.68
MP
+21.94%
$95.52
BTBT
+5.58%
$3.97
IREN
+7.31%
$64.14
NAKA
-1.56%
$0.85
RIG
+3.73%
$3.19
WBD
-3.22%
$17.10
UAMY
+36.85%
$16.71
NOK
-1.50%
$5.24
ABAT
+33.25%
$8.99
UUUU
+16.88%
$23.77
MARA
+8.52%
$20.23
EOSE
+23.37%
$17.05
PLTR
+1.00%
$177.21
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
XCH
+103.41%
$1.68
AAL
+1.51%
$11.69
TMQ
-9.46%
$5.93
BULL
+2.98%
$11.74
T
-1.14%
$25.57
RF
+1.63%
$24.55
SRM
+53.27%
$10.30
GDXD
-13.54%
$0.73
IONQ
+18.72%
$83.88
GOOGL
-2.05%
$236.57
QSI
+24.55%
$2.08
BMNR
+7.40%
$56.35
CLF
-7.18%
$13.18
VALE
+2.37%
$11.00
CLSK
+2.49%
$19.76
SMR
+14.72%
$45.02
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
RGTZ
-50.00%
$9.30
SLB
+1.71%
$32.26
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
ORCL
-1.34%
$292.95
ABEV
+1.18%
$2.13
NEHC
-8.12%
$2.60
BE
+26.54%
$109.93
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
TMC
+20.31%
$10.69
KDLY
-7.21%
$0.87
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.